Loading quotes...
Forecast
| Buy |
Â
0 |
| Hold |
Â
1 |
| Sell |
Â
0 |
News Go to news feed
DKSH signs distribution and service partnership with Novartis for ophthalmology in Singapore
DKSH will take on agency responsibilities in Singapore for Novartisâs ophthalmology portfolio, including sales, marketing, as well as credit and debt collection services. The aim of the strategic partnership is to improve patient care and to provide targeted support to healthcare professionals in ophthalmology. » More on finanzen.net
DKSH expands Performance Materials into the pet care market
DKSH subsidiary Performance Materials is expanding its business in ingredients for pet care, extending its formulation capabilities, innovation centers and raw material portfolio. DKSH will support manufacturers with ingredient selection, formulation development, product optimization and marketing. The company cites growing demand for products addressing skin health, coat care, odor control and pets' overall wellbeing. » More on finanzen.net
DKSH closes distribution deal for Ferrara candies in Asia-Pacific
DKSH has agreed a partnership with the Ferrara Candy Company and will handle import, distribution, logistics, as well as sales and marketing of Nerds Gummy Clusters in New Zealand, Hong Kong and Singapore. In selected markets DKSH holds exclusive rights. The launch in New Zealand already took place in early 2026. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 5.93bn | - |
| Gross profit | 386.22m | - |
| Net profit | 109.53m | - |
| EBITDA | 228.15m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | âŹ5.41bn |
Number of shares | 64.9m |
52-week high/low | âŹ83.84 - âŹ57.53 |
Dividend yield | 3.24% |
Dividends TTM | âŹ2.71 |
Beta | 0.44 |
P/E ratio | 22.63 |
PEG ratio | 1.79 |
P/B ratio | 2.81 |
P/S ratio | 0.45 |
Company profile
DKSH Holding AG provides various market expansion services in Thailand, Greater China, Malaysia, Singapore, rest of the Asia Pacific, and internationally. The company offers sourcing, marketing, sales, distribution, and after-sales services. It operates through four segments: Healthcare, Consumer Goods, Performance Materials, and Technology. The Healthcare segment provides various services, such as registration, regulatory, market entry studies, importation, customs clearance, marketing and sales, physical distribution, invoicing, and cash collection services for ethical pharmaceuticals, consumer health, and over-the-counter health products, as well as medical devices. The Consumer Goods segment offers a range of services, including product feasibility studies, registration, importation, customs clearance, marketing and merchandising, sales, warehousing, physical distribution, invoicing, cash collection, and after-sales services for fast moving consumer goods, food services, luxury goods, and fashion and lifestyle products, as well as hair and skin cosmetics. The Performance Materials segment sources, markets, and distributes a range of specialty chemicals and ingredients for the pharmaceutical, personal care, food and beverage, and industrial applications, as well as provides market expansion services for performance materials. The Technology segment offers market expansion services comprising a range of capital investment goods and analytical instruments in the areas of infrastructure, industrial materials and supplies, precision and textile machinery, semiconductors, photovoltaic and electronics, agriculture, and hospitality, as well as specialized industrial applications. The company was founded in 1865 and is based in Zurich, Switzerland.
| Name | DKSH Holding |
| CEO | Stefan Butz |
| Headquarters | Zurich,
zh Switzerland |
| Website | |
| Sector | Industrials |
| Industry | Professional Services |
| IPO | 19/04/2023 |
| Employees | 24,799 |
Ticker symbols
| Exchange | Symbol |
|---|---|
SIX | DKSH.SW |
London Stock Exchange | 0QQE.L |
Pnk | DKSHF |
London | 0QQE.L |
MĂŒnchen | DS5.MU |